MRK vs PLTR: Which Is the Better Buy?
Side-by-side comparison of Merck & Co., Inc. and Palantir Technologies Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-16.
Merck & Co., Inc. · Healthcare
$121.42
-2.9% upside to fair value
Med Conviction
Grade B
VS
Palantir Technologies Inc. · Technology
$142.76
-24.3% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
MRK has more upside to fair value
(-2.9%).
MRK trades at a lower forward P/E
(14.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MRK |
PLTR |
| Current Price |
$121.42 |
$142.76 |
| Fair Value Estimate |
$118.00 |
$108.00 |
| Upside to Fair Value |
-2.9%
|
-24.3%
|
| Market Cap |
$300.2B |
$327.1B |
| Forward P/E |
14.0x
|
209.7x
|
| EV / EBITDA |
11.8x
|
—
|
| Price / Sales |
4.1x
|
73.1x
|
| Price / FCF |
21.4x
|
155.7x
|
| Revenue Growth YoY |
+1.3%
|
+19.1%
|
| Gross Margin |
81.5%
|
82.4%
|
| Operating Margin |
41.2%
|
31.6%
|
| Return on Equity |
34.7%
|
25.7%
|
| Dividend Yield |
3.1% |
— |
| FCF Yield |
4.7%
|
0.6%
|
| Analyst Consensus |
Buy
|
Buy
|
Investment Thesis
Merck is a top-5 global pharmaceutical company generating $65B in annual revenue with 81.5% gross margins and 28% net margins. Keytruda, the world's best-selling drug at $31.7B (49% of pharma revenue), faces patent expiry in 2028. Merck is aggressively building replacements through M&A and pipeline launches: Winrevair ($1.4B year one), Capvaxive ($759M), and the $6.7B Terns acquisition for TERN-7…
Palantir Technologies develops data analytics and AI software platforms like Gotham and Foundry for government and commercial clients. The business excels with high margins (gross 82.4%, net 36.3%), accelerating growth (Q4 FY2025 revenue up 70% YoY to $1.41B, 2026 guidance $7.19B implying 61% growth), and strong moats in defense and enterprise AI, but trades expensively at 73x P/S versus 5-year m…
Accumulation Zones
| Metric |
MRK |
PLTR |
| Zone Low |
$88.00 |
$81.00 |
| Zone High |
$100.00 |
$92.00 |
| In Buy Zone? |
No
|
No
|